Fever In the Returned Traveler — Emergency Department
Fever In the Returned Traveler — Emergency Department
Disposition
Discharge
Discharge Considerations for the Febrile Returned Traveler
- No concern for highly communicable disease of public health importance (e.g. measles, Ebola)
- Normal/reassuring VS and labs
- Nontoxic appearing/able to self-hydrate
- Low suspicion for falciparum malaria
- Follow-up in 24 hours is possible
- Reachable by telephone for results (e.g. malaria smear)
- Non-falciparum malaria may be discharged if they demonstrate ability to take PO meds in ED, and have solid follow-up plan
Discharge Instructions
- PMD follow-up in 24 hrs
- Patients returning from dengue endemic areas and concern for dengue should have daily CBC until afebrile for > 48 hrs to assess for subtle signs of plasma leakage/developing dengue hemorrhagic fever (DHF), including:
- Hemoconcentration, defined by > 20% increase in hematocrit
(above average for age or compared to the previous day)
or - > 20% post-volume drop in hematocrit if IVF received
- Thrombocytopenia (< 100 K)
CBC can be rechecked by PCP or via return ED visit.
Contact PCP to ensure adequate follow-up is possible and type recommended labs in discharge instructions. - Hemoconcentration, defined by > 20% increase in hematocrit
- Infectious Diseases outpatient follow-up as needed and per their recommendations
Admission Considerations
- Any concerning lab value
- Abnormal VS, concerning clinical exam
- Inability to tolerate adequate PO
- High Suspicion for or diagnosis of falciparum malaria of any severity
- Admit for observation even if well appearing — at risk for clinical deterioration
- Dengue hemorrhagic fever criteria met
- Concern for highly communicable disease of public health importance
- As per IP&C or Department of Public Health
- Any concerns about ability to follow up/return to care
PICU |
|
---|---|
Inpatient General Peds |
|